Repair Impact Fund Investor
Novo Holdings established the REPAIR Impact Fund commissioned by the Novo Nordisk Foundation in February 2018 to invest in companies involved in discovering and the early-stage development of therapies targeting resistant microorganisms.
REPAIR is an acronym: Replenishing and Enabling the Pipeline for Anti-Infective Resistance.
The Novo Nordisk Foundation is commissioning the initiative, and Novo Holdings is executing it.
Number Of Exists:
3
Investor Type:
Donors
Employee Number:
1-10
Headquarters:
Hellerup, Hovedstaden, Denmark, Europe
Founded Date:
2018-02-01
Industry:
Biopharma & Life Science Tools
Number Of Investment/Funding Rounds:
12
City:
Hellerup
Region:
Hovedstaden
Country:
Denmark